Clinical trial
The Safety and Clinical Effectiveness of Pipeline™ Flex Embolization Devices With Shield Technology™ in Patients With Intracranial Aneurysms: a Multicentre Retrospective Study of an Australian Cohort (SCOPE-AUS)
NCT03815149 is registered in ClinicalTrials.gov with Gold Coast Hospital and Health Service as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Safety and Clinical Effectiveness of Pipeline™ Flex Embolization Devices With Shield Technology™ in Patients With Intracranial Aneurysms: a Multicentre Retrospective Study of an Australian Cohort (SCOPE-AUS)
- Lead sponsor
- Gold Coast Hospital and Health Service
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 30, 2019
- Completion date
- September 30, 2020
- Enrollment
- 500 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
cerebral aneurysm, cerebral hemorrhage, cerebral stroke, intracranial aneurysm, neurologic disorder, stroke, acute, subarachnoid hemorrhage